<DOC>
	<DOCNO>NCT01278173</DOCNO>
	<brief_summary>The purpose study evaluate change visual field mean automate static perimetry evaluate change retinal structure mean spectral domain optical coherence tomography ( SD-OCT ) adult patient refractory complex partial seizure ( CPS ) treat vigabatrin ( Sabril® )</brief_summary>
	<brief_title>A Study Structure Function Retina Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin ( Sabril® )</brief_title>
	<detailed_description>Multicenter , prospective open-label study approximately 25 site US specialize care adult patient refractory CPS - Sites must access Humphrey static perimetry Spectralis SD-OCT. - All vision test result send central reader evaluation . - Additional study test : - The Columbia Suicide Severity Rating Scale ( C-SSRS ) - The National Eye Institute Visual Field Questionnaire-39 ( NEI VFQ-39 ) - A whole blood sample specific analysis DNA characteristic - An optional whole blood sample exploratory analysis DNA characteristic - Plasma sample bioanalytical analysis vigabatrin blood sample taurine biomarker analysis</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Vigabatrin</mesh_term>
	<criteria>Important 1 . The patient speaks English Spanish . 2 . The patient prior exposure Sabril . 3 . To begin Sabril therapy treatment CPS . 4 . Male female ≥18 year age . 5 . The patient refractory CPS : 1 . The patient complex partial epilepsy 1 year duration seizure type within past year except partial seizure secondarily generalize . 2 . The patient fail lack efficacy 3 prior concurrent treatment trial include 3 antiepileptic drug ( AEDs ) differ pharmacologic mechanism administer monotherapy polytherapy . 3 . The patient take least 1 AED . A vagal nerve stimulator count AED . 4 . The patient report average 2 seizure per month average prior 3 month . 6 . The patient deem treating neurologist ophthalmologist able reliably complete perimetry test . 7 . The initial ( Visit 1 ) SDOCT static perimetry reading test must perform assessed technical adequacy SDOCT perimetry central reader prior first dose Sabril . The initial ( Visit 1 ) tangent corner test must perform prior first dose Sabril . 1 . Prior exposure Sabril . 2 . Preexisting ocular neurological disease might affect bilateral visual field interfere perimetry ( e.g. , aphakia , visually significant cataract , glaucoma , diabetes mellitus , ischemic optic neuropathy , multiple sclerosis ) . Patients stable visual field defect CNS lesion ( e.g. , epilepsy surgery 6 month prior receive Sabril ) may enrol . 3 . Concurrent exposure medication know suspected retinal optic nerve toxicity . 4 . Concurrent use investigational agent device use within 30 day enter study . 5 . Concurrent use ketogenic similar diet . 6 . For reason , patient consider investigator unsuitable candidate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Vigabatrin-associated vision change</keyword>
	<keyword>Adult refractory complex partial seizure</keyword>
	<keyword>CPS</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Seizures</keyword>
	<keyword>Brain disease</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Neurologic Manifestations</keyword>
	<keyword>Enzyme Inhibitors</keyword>
	<keyword>GABA Agents</keyword>
</DOC>